1 Factors Associated with Regional Variation in Medicare Part D Prescription Drug Plan Participation and Beneficiary Leslie M. Greenwald, Ph.D. Principal.

Slides:



Advertisements
Similar presentations
Optima Medicare (PPO) Plans CY Medicare Medicare is a Federal health insurance program for those age 65 or older or individuals at any age who have.
Advertisements

DataBrief: Did you know… DataBrief Series ● February 2011 ● No. 12 Dual Eligibles Across the States In 2008, dual eligibles as a percent of the total Medicare.
Teleconference 2 1.Guest speakers in May 2.Policy Brief Project The Employer and Health Insurance.
The Affordable Care Act Reduces Premium Cost Growth and Increases Access to Affordable Care Before ACA, Small Employers Faced Many Obstacles to Covering.
The Michigan Healthcare Marketplace Eileen Ellis Health Management Associates Initial Observations.
Medicare Supplement vs Medicare Advantage For authorized agent use only. Not for public use.
Congressional Budget Office Presentation to the National Health Policy Conference The Outlook for Health Care Spending February 4, 2008.
Click here to advance to the next slide.. Chapter 35 Life and Health Insurance Section 35.2 Health Insurance.
The Affordable Care Act What It Means for You Marcia H. Salkin Managing Director, Legislative Policy NAR Government Affairs.
1 Managed Health Care Pricing for Provider Arrangements Presented by Vanessa Olson Seminar on Health and Managed Care October 18, 1999.
Congressional Budget Office Presentation to The Tax Policy Center and the American Tax Policy Institute Taxes and Health Insurance February 29, 2008.
Healthcare Finances HS II Unit 1.03.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.
Section 5: Public Health Insurance Programs Medicare Medical Assistance (Medicaid) MinnesotaCare General Assistance Medical Care (GAMC) Minnesota Comprehensive.
HEALTH INSURANCE EXCHANGES: DESIGN ISSUES OREGON HEALTH POLICY BOARD DECEMBER 2009 Kramer Health Care Consulting.
Mr. Woodington’s Money Management II.  Options for individuals seeking health insurance not covered by their employer  Tips for purchasing individual.
Impact of Multi-Tiered Copayments on Cost and Use of Prescription Drugs among the Elderly Presented at AcademyHealth Annual Research Meeting Presented.
MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.
1 Benefits in Health Insurance: Calculating the Costs and Premiums Alliance for Health Reform October 10, 2008 John Bertko, FSA, MAAA.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
Effect of Cost-Sharing on Screening Mammography in Medicare Managed Care Plans Amal Trivedi, MD, MPH William Rakowski, PhD John Ayanian, MD, MPP 2007 AcademyHealth.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
(c) 2012 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
Excess cost growth in Medicare, Medicaid, and all other health care spending Source: CBO, A Federal Perspective on Health Care Policy and Costs, 2008.
January National Medicare & You Training Program Amy Larrick, CMS NAACP April 27, 2006.
Medicare Advantage Overview Diane Rowland, Sc.D. Executive Vice President Kaiser Family Foundation Alliance for Health Reform July 16, 2007.
Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments John Robst Melvin Ingber Jesse Levy Centers for Medicare & Medicaid Services.
THE EMPLOYER’S ROLE IN MEDICARE Henry de Vos Lawrie, Jr.Kathryn J. Greenlief McGuire Woods BattleUSAA & Boothe LLP.
Medicare Part D and the Financial Protection of the Elderly Gary V. Engelhardt Syracuse University Jonathan Gruber MIT.
Agribusiness Library LESSON: HEALTH INSURANCE. Objectives 1. Determine the function of health insurance, and define common health insurance terms. 2.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
THE COMMONWEALTH FUND Medicare Part D: What Are The Concerns? Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund Association.
1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.
11/8/051 Medicare Prescription Drug Benefits Employee Workshop November 2005.
0 Beneficiary Choices in Medicare Part D and Plan Features in 2006 Supported by PhRMA September 13, 2006.
Chart 1.1: Total National Health Expenditures, 1980 – 2011 (1) Source: Centers for Medicare & Medicaid Services, Office of the Actuary. Data released.
Avalere Health LLC | The intersection of business strategy and public policy The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries.
Chartbook 2005 Trends in the Overall Health Care Market Chapter 1: Trends in the Overall Health Care Market.
THE COMMONWEALTH FUND Figure 1. Medicare’s Success in Achieving Major Goals “How successful has Medicare been in accomplishing each of the following specific.
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
Slide -1 Medicare Prescription Drug Coverage Atlanta Regional Office Centers for Medicare & Medicaid Services September 12, 2005.
“For the vast majority of seniors, the new benefit is working.” -Mark McClellan, CMS, February 2006 "It's a disaster, Medicare Part D - D is unfortunately.
MEDICARE ADVANTAGE: WHAT CONGRESS INTENDED? by Marsha Gold, Sc.D. Senior Fellow Mathematica Policy Research June 3, 2007 For presentation at Panel on “Medicare.
Benefit Design in Health Care Reform Paul B. Ginsburg, Ph.D. Alliance for Health Reform, Congressional Health Care Reform Educational Project, October.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
Exhibit 1 NOTES: LIS is Low-Income Subsidy. PDP is prescription drug plan. MA-PD is Medicare Advantage Prescription Drug Plan. Analysis includes non-LIS.
1 Comprehensive Health Care Reform in Vermont: The Policy and Politics Jim Maxwell, PhDHerb Olson, JD JSI Research & Training Institute, Inc. Vermont Department.
1 Cost Sharing for Low-Income Beneficiaries and Supplementing Part D Examples from Pharmacy Plus Medicaid Demonstration Programs Summit for State Health.
Hospital Utilization by Fee-for-Service and Medicare Advantage Enrollees Lauren Hersch Nicholas University of Michigan September 15, 2009.
1 Federal Employees Health Benefits Program: Competition and Other Factors Linked to Wide Variation in Health Care Prices Christine Brudevold Assistant.
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
1.03 Healthcare Finances. Health Insurance Plans Premium-The periodic amount paid to an insurance company for healthcare or prescription drugs Deductible-Amount.
Chart 1.1: Total National Health Expenditures, 1980 – 2013 (1) Source: Centers for Medicare & Medicaid Services, Office of the Actuary. Data released.
Medicare Managed Care. Plan for Medicare Managed Care Today –Enrollment patterns and trends –Pros and cons for beneficiaries –How Medicare has traditionally.
Appendices. Appendix 1: Supplementary Data Tables Trends in the Overall Health Care Market.
Estimating the Cost of the Medicare Drug Benefit Philip Ellis Steve Lieberman Medicare Prescription Drug Congress February 27, 2004.
MEDICARE PART D July MEDICARE PART D: OVERVIEW Part D provides prescription drug coverage for Medicare beneficiaries. Prescription drug plans compete.
State Child Buy-In Programs: A Snapshot Dawn Horner Georgetown Center for Children and Families Families USA January 30, 2009.
Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.
Premium Sensitivity Among Workers Chapter What Is the Relevant Premium? The “risk premium”? The “risk premium”? The “loading fee”? The “loading.
Retiree Coverage Chapter The Vast Majority of Medicare Beneficiaries Have Some Form of Supplemental Coverage.
Risk Adjustment Chapter 6. 2 Medicare AAPCC: Adjusted Average Per Capita Costs Average Medicare Part A + Part B expenditures Average Medicare Part A +
Brian C. Martin, Ph.D., MBA East Tennessee State University
Health Insurance Pricing
1.03 Healthcare Finances.
Program strategies Government as predictable business partner
Discussion Topics History of Private Plans in Medicare
Discussion Topics Factors Influencing Plan Participation
Employer-Sponsored Insurance and Medicare Spending per Enrollee, Relative to U.S Median Spending for Each Population, 2014 Per-Enrollee Spending: Employer-Sponsored.
Presentation transcript:

1 Factors Associated with Regional Variation in Medicare Part D Prescription Drug Plan Participation and Beneficiary Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International

2 RTI colleagues who participated in this research Judith Shinogle John Kautter Elisabeth Root Dan Crespin Greg Pope

3 Purpose Understand the factors that influence regional variation in Medicare Part D prescription drug plan (PDP) participation and beneficiary premiums. Gain insight into regional characteristics that may be attractive to Medicare PDPs Identification of regional characteristics “attractive” to PDPs may help policy makers predict long term PDP plan participation “Region”, in this work, refers to the 34 Medicare PDP regions.

4 Methods Data on PDP regional characteristics were developed from a comprehensive database of U.S. Census, Medicare administrative files, the Area Resource File, Interstudy, AARP, and other sources. Regional characteristics included: Population Characteristics Payment Rates, Cost and Disease Risk Insurance Market Characteristics General Provider Supply Characteristics The number of PDP plan options and average monthly premiums charged were correlated (Pearsons r) with regional characteristics available in this database.

5 Findings: Total PDP Plans by PDP Region Map Total Number of PDP Plans by PDP Region, 2006

6 Findings: Average Total Monthly PDP Part D Premium by PDP Region Average Total Monthly PDP Part D Premium by PDP Region, 2006

7 Findings: Relationship Between Population Characteristics and PDP Participation/Premiums Both the number of defined standard benefit, and total number of PDP plans in each PDP region, are correlated to the total number of elderly and number of Medicare eligible beneficiaries in each region. Also found positive relationships between the total number of PDP plans and the number of Medicare managed care enrollees. Results suggest, not surprisingly, regions with larger potential enrollment pools attract more PDP plans.

8 Findings: Relationship between Population Characteristics and PDP Participation/Premiums Also noted relationships between population characteristics and PDP plan premiums at the regional level. Total (basic and total) premiums were negatively correlated to various measures of population size. Suggests, in general, that the greater the population size, the lower the average premiums. Exceptions: found strongly positive relationships between the percent of elderly living in poverty and the percent of elderly living in rural areas and premium levels. Findings indicate that regions with larger proportions of traditionally higher cost populations are likely to face higher average premiums.

9 Findings: Relationship between Payment Rates, Cost, Disease Risk and PDP Participation/Premiums Few payment rate or cost/disease factors were related to number of PDP plans at the regional level. May reflect that there is little actual relationship between historic Medicare payment rates and payment for the new PDP plans. Observed a positive correlation between the number of PDP plans and higher CMS HCC risk scores. One might expect insurers would avoid areas with higher risk scores. Also found a positive correlation between the percent of Medicare beneficiaries with Medicaid coverage (dual eligibles) and higher premiums, suggesting perhaps that regions with greater percentages of dual eligible beneficiaries may be perceived by plans to be higher cost.

10 Findings: Relationship between Insurance Market Characteristics and PDP Participation/Premiums Insurance market characteristics were correlated to the total number of PDPs at the regional level. Percent of total and Medicare population in an HMO plan was positively correlated with number of PDPs in a region. Relationship may indicate that PDP organizations, many of whom also offer HMOs and other managed care products, are attracted to regions with existing HMO penetration. Also found that the total number of PDPs was negatively correlated with the percent of total population enrolled in any PPO plans, suggesting that PPO penetration (at least by risk bearing PPOs) is not an attractive regional characteristic to potential PDP organizations. Regions with higher HMO and Medicare penetration in HMOs were associated with lower average monthly premiums. Conversely, regions with higher PPO penetration were associated with higher total PDP premiums.

11 Findings: Relationship between Insurance Market Characteristics and PDP Participation/Premiums Also noted interesting relationships between the number of PDP plans at the regional level, and both the market share and number of private insurers operating in that region. Fewer PDP plans were associated with PDP regions where the largest private insurer had greater market share. Similarly, noted a positive correlation between the number of private insurers and the total number of PDP plans. Findings may suggest that the presence of a dominant existing large private insurer – perhaps offering coverage to a dominant employer or group of employers – may be a deterrent to a larger number of PDP plans.

12 Discussion and Conclusions Medicare Part D standalone PDPs are widely available to Medicare beneficiaries in all regions, though the number and cost of these plans vary and are related to key PDP regional characteristics. Our findings are generally consistent with views expressed by PDP organizations, including: that more sparsely populated would have fewer PDPs and face higher premiums; and that the structure of health insurance markets in the PDP regions would affect the viability of the new Part D products.

13 Discussion and Conclusions Characteristics of the PDP regions insurance markets, particularly penetration of HMOs versus PPOs, and market share of existing large private insurers, also appear to be related to the number and pricing of PDP products. Currently options are widely available, however, attention to these characteristics may help policy makers understand and predict where PDPs may be successful in future years as the market for this benefit matures.